Related references
Note: Only part of the references are listed.Research Progress of PARP Inhibitor Monotherapy and Combination Therapy for Endometrial Cancer
Ke Shen et al.
CURRENT DRUG TARGETS (2022)
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
C. C. B. Post et al.
GYNECOLOGIC ONCOLOGY (2022)
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
Anne Sophie V. M. van den Heerik et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma
Mohammad Reza Alivand et al.
CANCER GENETICS (2021)
TTK inhibitor promotes radiosensitivity of liver cancer cells through p21
Haibo Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Hiroyoshi Nishikawa et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Immunotherapy in endometrial cancer: rationale, practice and perspectives
Wenyu Cao et al.
BIOMARKER RESEARCH (2021)
RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma
Hongxia Dan et al.
MOLECULAR ONCOLOGY (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
Cathalijne C. B. Post et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Annalisa Del Prete et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma
Henrike B. Zech et al.
FUTURE ONCOLOGY (2020)
Endogenous Glucocorticoid Signaling Regulates CD8+T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment
Nandini Acharya et al.
IMMUNITY (2020)
Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer
Dengbo Ji et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma
Iikki Donner et al.
FAMILIAL CANCER (2019)
Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
R. L. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
Joo Sang Lee et al.
JAMA ONCOLOGY (2019)
Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer
Zi-Hao Wang et al.
CANCER CELL INTERNATIONAL (2019)
Harnessing innate immunity in cancer therapy
Olivier Demaria et al.
NATURE (2019)
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Matthew D. Hellmann et al.
CANCER CELL (2018)
When worlds collide: Th17 and Treg cells in cancer and autoimmunity
Hannah M. Knochelmann et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Management Strategies for Recurrent Endometrial Cancer
Elizabeth V. Connor et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer
Rajmohan Murali et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
Fei Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein
Yulei Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman et al.
LANCET (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters
Janelle B. Pakish et al.
CLINICAL CANCER RESEARCH (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Immune regulation by glucocorticoids
Derek W. Cain et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Piera Gargiulo et al.
CANCER TREATMENT REVIEWS (2016)
Homologous recombination deficiency and ovarian cancer
Jonathan A. Ledermann et al.
EUROPEAN JOURNAL OF CANCER (2016)
Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma
Orsolya Galamb et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
FastRFunctions for Robust Correlations and Hierarchical Clustering
Peter Langfelder et al.
Journal of Statistical Software (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors
Kirsten A. Nesset et al.
EPIGENETICS (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Loss of Glucocorticoid Receptor Expression by DNA Methylation Prevents Glucocorticoid Induced Apoptosis in Human Small Cell Lung Cancer Cells
Paul Kay et al.
PLOS ONE (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer
R. A. de Jong et al.
GYNECOLOGIC ONCOLOGY (2009)
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Sergio Pecorelli
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
p53 and E2f: partners in life and death
Shirley Polager et al.
NATURE REVIEWS CANCER (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region:: identification, and tissue distribution of multiple new human exon 1
JD Turner et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic
SM Phillips et al.
BRITISH JOURNAL OF SURGERY (2004)
Share Paper
